Hyperbaric oxygen treatment and N-acetylcysteine ameliorate acetaminophen-induced liver injury in a rat model

Human and Experimental Toxicology

Volumn 32, Issue 10, 2013, Pages 1107-1116

  Taslipinar, M Y ^a   Aydin, I ^b   Kaldirim, U ^b   Aydin, F N ^b   Agilli, M ^b   Eyi, Y E ^b   Tuncer, S K ^b   Altayli, E ^b   Ucar, F ^a   Macit, E ^b   Toygar, M ^b   Yigit, N ^b   Cayci, T ^b  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acetaminophen; hyperbaric oxygen; inflammation; liver injury; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 6; NEOPTERIN; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA; WATER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; HYPERBARIC OXYGEN; LIVER NECROSIS; LIVER PROTECTION; MALE; NONHUMAN; OXYGEN BREATHING; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STOMACH TUBE; TOXIC HEPATITIS;

ANIMALIA; RATTUS;

ACETAMINOPHEN; HYPERBARIC OXYGEN; INFLAMMATION; LIVER INJURY; N-ACETYLCYSTEINE;

ACETAMINOPHEN; ACETYLCYSTEINE; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HYPERBARIC OXYGENATION; INTERLEUKIN-6; LIVER; MALE; NEOPTERIN; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886411326     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113499167     Document Type: Article

References (46)

1. Shi Y, Zhang L, Jiang R, et al. Protective effects of nicotinamide against acetaminophen-induced acute liver injury. Int Immunopharmacol. 2012 ; 14: 530-537
2. Yaman H, Isbilir S, Cakir E, et al. Current issues with paracetamol induced toxicity. J Exp Integr Med. 2011 ; 1: 165-166
3. Ganey PE, Luyendyk JP, Maddox JF, et al. Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact. 2004 ; 150: 35-51
4. Zimmermann HW, Tacke F. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflamm Allergy Drug Targets. 2011 ; 10: 509-536
5. Galun E, Axelrod JH. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta. 2002 ; 1592: 345-358
6. Blazka ME, Wilmer JL, Holladay SD, et al. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 1995 ; 133: 43-52
7. Ishida Y, Kondo T, Ohshima T, et al. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 2002 ; 16: 1227-1236
8. Masubuchi Y, Bourdi M, Reilly TP, et al. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun. 2003 ; 304: 207-212
9. Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol. 2008 ; 84: 1410-1421
10. Rossignol DA. Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis. Med Gas Res. 2012 ; 6: 2
11. Simsek K, Ay H, Topal T, et al. Long-term exposure to repetitive hyperbaric oxygen results in cumulative oxidative stress in rat lung tissue. Inhal Toxicol. 2011 ; 23: 166-172
12. Yamanel L, Kaldirim U, Oztas Y, et al. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. Int J Med Sci. 2011 ; 8: 48-55
13. Altinel O, Demirbas S, Cakir E, et al. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest. 2011 ; 71: 185-192
14. Ay H, Topal T, Ozler M, et al. Persistence of hyperbaric oxygen-induced oxidative effects after exposure in rat brain cortex tissue. Life Sci. 2007 ; 80: 2025-2029
15. Akgul EO, Cakir E, Ozcan O, et al. Pressure-related increase of asymmetric dimethylarginine caused by hyperbaric oxygen in the rat brain: a possible neuroprotective mechanism. Neurochem Res. 2007 ; 32: 1586-1591
16. Koca K, Yurttas Y, Bilgic S, et al. Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats. J Surg Res. 2010 ; 164: e83 - e89
17. Zafarullah M, Li WQ, Sylvester J, et al. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003 ; 60: 6-20
18. James LP, McCullough SS, Lamps LW, et al. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci. 2003 ; 75: 458-467
19. Fernando B, Marley R, Holt S, et al. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat.. Hepatology. 1998 ; 28: 689-694
20. Ferreira AP, Pasin JS, Saraiva AL, et al. N-Acetylcysteine prevents baker's-yeast-induced inflammation and fever. Inflamm Res. 2012 ; 61: 103-112
21. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 ; 193: 265-275
22. Agilli M, Yaman H, Cayci T, et al. Comparison of two different HPLC methods and elisa method for measurement of serum neopterin. J Investig Biochem. 2012 ; 1: 43-47
23. Gul H, Uysal B, Cakir E, et al. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environ Toxicol Pharmacol. 2012 ; 34: 81-86
24. Li F, Fang L, Huang S, et al. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production. Anesth Analg. 2011 ; 113: 626-633
25. Gardner CR, Laskin JD, Dambach DM, et al. Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol. 2003 ; 192: 119-130
26. James LP, McCullough SS, Lamps LW, et al. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci. 2003 ; 75: 458-467
27. Ishida Y, Kondo T, Ohshima T, et al. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 2002 ; 16: 1227-1236
28. Dambach DM, Durham SK, Laskin JD, et al. Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol Appl Pharmacol. 2006 ; 211: 157-165
29. Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 2006 ; 44: 34-43
30. Palacio JR, Markert UR, Martinez P. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflamm Res. 2011 ; 60: 695-704
31. Roman-Blas JA, Contreras-Blasco MA, Largo R, et al. Differential effects of the antioxidant n-acetylcysteine on the production of catabolic mediators in IL-1beta-stimulated human osteoarthritic synoviocytes and chondrocytes. Eur J Pharmacol. 2009 ; 623: 125-131
32. Nascimento MM, Suliman ME, Silva M, et al. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int. 2010 ; 30: 336-342
33. Dodd S, Dean O, Copolov DL, et al. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008 ; 8: 1955-1962
34. Radomska-Lesniewska DM, Sadowska AM, Van Overveld FJ, et al. Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells. J Physiol Pharmacol. 2006 ; 57 (Suppl 4). 325-334
35. Demirbas S, Cakir E, Akgul EO, et al. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environ Toxicol Pharmacol. 2011 ; 31: 165-170
36. Gelderblom HC, Zeuzem S, Weegink CJ, et al. Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a. Scand J Gastroenterol. 2008 ; 43: 1122-1127
37. Cakir E, Akgul OE, Aydin I, et al. The association between neopterin and acetaminophen-induced nephrotoxicity. Ren Fail. 2010 ; 32: 740-746
38. Yaman H, Cakir E, Ozcan O, et al. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem. 2005 ; 38: 187-190
39. Dragomir AC, Sun R, Choi H, et al. Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication. J Immunol. 2012 ; 189: 5934-5941
40. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology. 2004 ; 127: 1760-1774
41. Simsek K, Oter S, Ay H. Hyperbaric oxygen therapy and its mechanisms of action: implication of several molecular processes along with reactive species. J Exp Integr Med. 2011 ; 1: 205-206
42. Yang Z, Nandi J, Wang J, et al. Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-alpha and IL-1beta production. Dig Dis Sci. 2006 ; 51: 1426-1433
43. Sumen G, Cimsit M, Eroglu L. Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats. Eur J Pharmacol. 2001 ; 431: 265-268
44. Inamoto Y, Okuno F, Saito K, et al. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Commun. 1991 ; 179: 886-891
45. Guven A, Gundogdu G, Uysal B, et al. Hyperbaric oxygen therapy reduces the severity of necrotizing enterocolitis in a neonatal rat model. J Pediatr Surg. 2009 ; 44: 534-540
46. Oter S, Edremitlioglu M, Korkmaz A, et al. Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats. Intensive Care Med. 2005 ; 31: 1262-1268